Literature DB >> 6524989

Colchicine in systemic amyloidosis.

E Akoğlu, T Akoğlu, E Erken.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1984        PMID： 6524989      PMCID： PMC1001553          DOI： 10.1136/ard.43.6.857

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  7 in total

1.  Colchicine inhibition of casein-induced amyloidosis in mice.

Authors:  I Kedar; M Ravid; E Sohar; J Gafni
Journal:  Isr J Med Sci       Date:  1974-07

2.  Degenerative changes in the intervertebral discs of the lumbar spine and their sequelae.

Authors:  B Vernon-Roberts; C J Pirie
Journal:  Rheumatol Rehabil       Date:  1977-02

3.  Vertebral rim lesions in dorsolumbar spine.

Authors:  B Vernon-Roberts
Journal:  Ann Rheum Dis       Date:  1984-08       Impact factor: 19.103

4.  Prolonged colchicine treatment in four patients with amyloidosis.

Authors:  M Ravid; M Robson; I Kedar
Journal:  Ann Intern Med       Date:  1977-11       Impact factor: 25.391

5.  Vertebral rim lesions in the dorsolumbar spine.

Authors:  R C Hilton; J Ball
Journal:  Ann Rheum Dis       Date:  1984-04       Impact factor: 19.103

6.  DMSO and colchicine therapy in amyloid disease.

Authors:  M A Scheinberg; J C Pernambuco; M D Benson
Journal:  Ann Rheum Dis       Date:  1984-06       Impact factor: 19.103

7.  Blockage of amyloid induction by colchicine in an animal model.

Authors:  T Shirahama; A S Cohen
Journal:  J Exp Med       Date:  1974-10-01       Impact factor: 14.307
  7 in total
  1 in total

1.  Venetoclax and donor lymphocyte infusion for early relapsed acute myeloid leukemia after allogeneic hematopoietic cell transplantation. A retrospective multicenter trial.

Authors:  Odelia Amit; Yael Bar On; Galit Perez; Liat Shargian-Alon; Moshe Yeshurun; Ron Ram
Journal:  Ann Hematol       Date:  2021-01-13       Impact factor: 3.673
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.